References
- Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079–81.
- Karaiskos I, Lagou S, Pontikis K, Rapti V, Poulakou G. The "old" and the "new" antibiotics for MDR Gram-negative pathogens: for whom, when, and how. Front Public Health. 2019;7:151.
- Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, et al. Impact of rapid organism identification via matrix assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis. 2013;57(9):1237e45.
- Shields RK, Nguyen MH, Press EG, Chen L, Kreiswirth BN, Clancy CJ. Emergence of ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in Klebsiella pneumoniae Carbapenemase-producing K pneumoniae: a case report and review of literature. Open Forum Infect Dis. 2017;4(3):ofx101.
- Takissian J, Bonnin RA, Naas T, Dortet L. NG-Test Carba 5 for rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures. Antimicrob Agents Chemother. 2019;63(5):e00011.
- Mueller L, Masseron A, Prod’Hom G, Galperine T, Greub G, Poirel L, Nordmann P. Phenotypic, biochemical and genetic analysis of KPC-41, a KPC-3 variant conferring resistance to ceftazidime-avibactam and exhibiting reduced carbapenemase activity. Antimicrob Agents Chemother. 2019;63(12):e01111–19.
- Humphries RM, Hemarajata P. Resistance to ceftazidime-avibactam in Klebsiella pneumoniae due to porin mutations and the increased expression of KPC-3. Antimicrob Agents Chemother. 2017;61(6):e00537–17.
- Galani I, Antoniadou A, Karaiskos I, Kontopoulou K, Giamarellou H, Souli M. Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam. Clin Microbiol Infect. 2019;25(6):763.e5–763.e8.
- García J, Nastro M, Cejas D, Santana G, Mancino MB, Hidalgo M, et al. Emergence of ceftazidime/avibactam resistance in KPC-8-producing Klebsiella pneumoniae in South America. Clin Microbiol Infect. 2020;23. S1198-743X (20)30156-30157
- Rodriguez CH, Maza J, Tamarin S, Nastro M, Vay C, Famiglietti A. In-house rapid colorimetric method for detection of colistin resistance in Enterobacterales: A significant impact on resistance rates. J Chemother. 2019;31(7-8):432–5.
- Clinical and Laboratory Standards Institute. Twenty-sixth Informational Supplement. CLSI document M100–S29. Wayne (PA): Clinical and Laboratory Standards Institute; 2019. Performance standards for antimicrobial susceptibility testing.
- Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–23.
- Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum β-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2018;31:e00079.
- Rodriguez CH, Traglia G, Bastias N, Pandolfo C, Bruni G, Nastro M, et al. Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: the influence of slow growth and heteroresistance. Int J Antimicrob Agents. 2019;54(5):587–91.
- European Committee on Antimicrobial Susceptibility Testing. https://mic.eucast.org/Eucast2/SearchController/search.jsp?action=performSearch&BeginIndex=0&Micdif=mic&NumberIndex=50&Antib=733&Specium=-1.